Redmond, W. L., Koguchi, Y., Kasiewicz, M. J., Rolig, A. S., Holay, N., Becklund, B., . . . Durana, Y. D. d. INBRX-106: A hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clustering. BMJ Publishing Group.
Chicago Style (17th ed.) CitationRedmond, William L., et al. INBRX-106: A Hexavalent OX40 Agonist That Drives Superior Antitumor Responses via Optimized Receptor Clustering. BMJ Publishing Group.
MLA (9th ed.) CitationRedmond, William L., et al. INBRX-106: A Hexavalent OX40 Agonist That Drives Superior Antitumor Responses via Optimized Receptor Clustering. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.